Metropolis Healthcare Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 432.8431 crores during the period ended March 31, 2026 as compared to Rs. 414.9252 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 50.9030 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 41.3856 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 2.46 for the period ended March 31, 2026 as compared to Rs. 2.53 for the period ended December 31, 2025.
| Total Income | ₹ 432.8431 crs | ₹414.9252 crs | 4.32% |
| Net Profit | ₹50.9030 crs | ₹41.3856 crs | 23.00% |
| EPS | ₹2.46 | ₹2.53 | -2.77% |
Financial Results (Q4 FY2026) - YoY Comparison The company has reported total income of Rs. 432.8431 crores during the period ended March 31, 2026 as compared to Rs.352.2623 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.50.9030 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.21.9417 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.2.46 for the period ended March 31, 2026 as compared to Rs.1.42 for the period ended March 31, 2025.
| Total Income | ₹ 432.8431 crs | ₹352.2623 crs | 22.88% |
| Net Profit | ₹50.9030 crs | ₹21.9417 crs | 131.99% |
| EPS | ₹2.46 | ₹1.42 | 73.24% |
Financial Results (Year Ended FY2026) - YoY Comparison The company has reported total income of Rs.1671.4303 crores during the Financial Year ended March 31, 2026 as compared to Rs.1346.3160 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.190.0174 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.144.9683 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.9.19 for the Financial Year ended March 31, 2026 as compared to Rs.7.04 for the Financial Year ended March 31, 2025.
| Total Income | ₹1671.4303 crs | ₹1346.3160 crs | 24.15% |
| Net Profit | ₹190.0174 crs | ₹144.9683 crs | 31.08% |
| EPS | ₹9.19 | ₹7.04 | 30.54% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 548.10 as compared to the previous close of Rs. 548.00. The total number of shares traded during the day was 15052 in over 808 trades.
The stock hit an intraday high of Rs. 558.25 and intraday low of 541.50. The net turnover during the day was Rs. 8253174.00.
Source : Equity Bulls
Keywords
MetropolisHealthcare
Q4FY26
Q4FY2026
FY26
FY2026
ResultUpdate